Litcius/Paper detail

Nanobooster-encapsulated hybrid RNA as anti-tumor viral mimicry

Chang Liu, Yanfeng Zhou, Xiaoyuan Ji, Hui Xie, Xingjie Hu, Min Yin, Nan Chen, Chunhai Fan, Haiyun Song

2021Nano Today16 citationsDOIOpen Access PDF

Abstract

Innate sensing of viral RNA analogs represents a promising tool for cancer intervention, yet the tumor microenvironment (TME) renders tumor cells and immune cells unresponsive to exogenous innate stimuli. Herein, we design a hybrid RNA yielding both endogenous retrovirus and exogenous viral signature for orchestrated immune activation. Additionally, we encapsulate the RNA in a TME-responsive nanobooster, which generates oxygen to awaken hypoxia-mediated dormancy of viral RNA sensors. This two-in-one viral mimicry demonstrates synergistic effects on the production of type I interferons (α and β), maturation of dendritic cells and apoptosis of cancer cells, and further stimulates anti-tumor T cell immunity and memory. Significantly, monotherapy with the viral mimicry potently suppresses tumor growth, post-surgical relapse and metastasis in murine liver and breast cancer models, and exhibits long-term resistance against tumor re-challenge. Our study thus provides a straightforward but effective strategy for self-amplification of innate immunity in cancer therapy.

Topics & Concepts

Innate immune systemTumor microenvironmentBiologyRNAImmune systemCancer cellCancerMolecular mimicryCancer researchImmunologyGeneGeneticsRNA Interference and Gene Deliveryinterferon and immune responsesImmunotherapy and Immune Responses
Nanobooster-encapsulated hybrid RNA as anti-tumor viral mimicry | Litcius